1. Home
  2. PRI vs ABVX Comparison

PRI vs ABVX Comparison

Compare PRI & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primerica Inc.

PRI

Primerica Inc.

HOLD

Current Price

$257.66

Market Cap

8.3B

Sector

Finance

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$117.88

Market Cap

9.6B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRI
ABVX
Founded
1927
2013
Country
United States
France
Employees
N/A
N/A
Industry
Life Insurance
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
9.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PRI
ABVX
Price
$257.66
$117.88
Analyst Decision
Hold
Strong Buy
Analyst Count
4
12
Target Price
$304.25
$115.83
AVG Volume (30 Days)
233.4K
1.7M
Earning Date
11-05-2025
08-11-2025
Dividend Yield
1.61%
N/A
EPS Growth
65.97
N/A
EPS
21.75
N/A
Revenue
$3,335,204,000.00
$6,231,374.00
Revenue This Year
$4.64
$6.80
Revenue Next Year
$4.73
N/A
P/E Ratio
$11.89
N/A
Revenue Growth
10.41
N/A
52 Week Low
$230.98
$4.77
52 Week High
$298.75
$138.49

Technical Indicators

Market Signals
Indicator
PRI
ABVX
Relative Strength Index (RSI) 51.61 51.08
Support Level $256.40 $108.53
Resistance Level $263.12 $138.49
Average True Range (ATR) 4.66 7.25
MACD 0.72 -1.73
Stochastic Oscillator 62.59 28.51

Price Performance

Historical Comparison
PRI
ABVX

About PRI Primerica Inc.

Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the United States.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: